ANRO
Price
$2.30
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
63.62M
44 days until earnings call
RLAY
Price
$3.60
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
622.35M
37 days until earnings call
Interact to see
Advertisement

ANRO vs RLAY

Header iconANRO vs RLAY Comparison
Open Charts ANRO vs RLAYBanner chart's image
Alto Neuroscience
Price$2.30
Change-$0.00 (-0.00%)
Volume$967
Capitalization63.62M
Relay Therapeutics
Price$3.60
Change-$0.00 (-0.00%)
Volume$281
Capitalization622.35M
ANRO vs RLAY Comparison Chart in %
Loading...
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANRO vs. RLAY commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Hold and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ANRO: $2.35 vs. RLAY: $3.60)
Brand notoriety: ANRO and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 29% vs. RLAY: 0%
Market capitalization -- ANRO: $63.62M vs. RLAY: $622.35M
ANRO [@Biotechnology] is valued at $63.62M. RLAY’s [@Biotechnology] market capitalization is $622.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than ANRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • ANRO’s TA Score: 4 bullish, 5 bearish.
  • RLAY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than ANRO.

Price Growth

ANRO (@Biotechnology) experienced а +2.17% price change this week, while RLAY (@Biotechnology) price change was +8.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ANRO is expected to report earnings on Aug 19, 2025.

RLAY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($622M) has a higher market cap than ANRO($63.6M). RLAY YTD gains are higher at: -12.621 vs. ANRO (-44.444). ANRO has higher annual earnings (EBITDA): -60.98M vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. ANRO (161M). ANRO has less debt than RLAY: ANRO (26.4M) vs RLAY (47.2M). RLAY has higher revenues than ANRO: RLAY (7.68M) vs ANRO (0).
ANRORLAYANRO / RLAY
Capitalization63.6M622M10%
EBITDA-60.98M-373.07M16%
Gain YTD-44.444-12.621352%
P/E RatioN/AN/A-
Revenue07.68M-
Total Cash161M710M23%
Total Debt26.4M47.2M56%
TECHNICAL ANALYSIS
Technical Analysis
ANRORLAY
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APAAF0.120.02
+26.32%
APPIA RARE EARTHS & URANIUM CORP.
MRSKF21.43N/A
N/A
DMG Mori Co Ltd
WTBFB293.39N/A
N/A
W.T.B. Financial Corp.
BQCNF110.00N/A
N/A
Banque Cantonale Vaudoise
SDIIF0.66N/A
N/A
Scientific Digital Imaging PLC

ANRO and

Correlation & Price change

A.I.dvisor tells us that ANRO and NUVL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANRO and NUVL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANRO
1D Price
Change %
ANRO100%
+2.17%
NUVL - ANRO
30%
Poorly correlated
-0.02%
XTLB - ANRO
26%
Poorly correlated
+10.00%
RLAY - ANRO
26%
Poorly correlated
N/A
NTLA - ANRO
26%
Poorly correlated
+0.09%
BEAM - ANRO
25%
Poorly correlated
+0.65%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
N/A
XNCR - RLAY
52%
Loosely correlated
+1.45%
BCYC - RLAY
50%
Loosely correlated
-0.13%
IMNM - RLAY
49%
Loosely correlated
+2.43%
BDTX - RLAY
48%
Loosely correlated
-0.77%
RZLT - RLAY
46%
Loosely correlated
-0.82%
More